Filters:
Researcher receives $1.3 million grant to improve breast cancer treatment for Black women
Indiana University
An Indiana University Melvin and Bren Simon Comprehensive Cancer Center researcher is identifying the unique biology that may make Black women more susceptible to aggressive breast cancer.
John Theurer Cancer Center Urologic Oncologists Offer Access to Promising Immunotherapy Treatments for Genitourinary Cancers
Hackensack Meridian Health
Rutgers Cancer Institute of New Jersey Chair of Radiation Oncology and Associate Vice Chancellor Named President-Elect of the RSNA Board
Rutgers Cancer Institute of New Jersey
The Radiological Society of North America (RNSA) is an international society of radiologists, medical physicists and other medical professionals across the world, with the mission of promoting excellence in patient care and health care delivery through education, research and technologic innovation. This year, Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey has been named president-elect of the society.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Expansive New Hematology Data at the 62nd ASH Annual Meeting and Exposition
Rutgers Cancer Institute of New Jersey
The American Society of Hematology (ASH), is the world's largest professional society with a focus on the causes and treatment of blood disorders. Experts from Rutgers Cancer Institute of New Jersey will be presenting a variety of key hematology data at the 62nd American Society of Hematology Annual Meeting. This includes 22 scheduled presentations, including 10 oral presentations examining several types of blood cancers including leukemia, lymphoma, and myeloma.
Rutgers Researcher Receives $400K Grant to Reduce Racial Health Disparities in Cancer Care
Rutgers School of Public Health
Anita Kinney, professor at the Rutgers School of Public Health and associate director for Population Science and Community Outreach at Rutgers Cancer Institute of New Jersey, is one of ten recipients across the nation of an American Cancer Society and Pfizer community grant of $399,892 to support investigation into reducing racial health disparities in cancer care through precision oncology and immunotherapy.
Cancer cases are rising in adolescents and young adults
Penn State College of Medicine
Cancer cases in adolescents and young adults have risen by 30% during the last four decades, with kidney cancer rising at the greatest rate, according to researchers at Penn State College of Medicine.
Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Hackensack Meridian Health
Don't Delay Your Care - Our dnhanced pandemic safety precautions prioritize patient health and allow providers to deliver outstanding in-office, telehealth and surgical care
Hackensack University Medical Center Cancer Specialist Demonstrates Safety of Novel Immuno-Oncology Agent in Patients with Advanced Solid Tumors
Hackensack Meridian Health
OX40 Agonist Appears Safe When Used Alone or in Combination with Checkpoint Inhibitor Therapy
Baylor Scott & White Medical Center - Temple Performs 1000th HoLEP Procedure That Improves Men's Quality of Life
Baylor Scott and White Health
In mid-October, Baylor Scott & White Medical Center - Temple conducted its 1000th holmium laser enucleation of the prostate (HoLEP), a minimally invasive procedure that can address benign prostatic hyperplasia (BPH). BPH can prevent the bladder from emptying properly and could lead to kidney damage or failure. It also impacts quality of life in about one third of men older than 50 years old.
Southwest Virginia Residents Leading Region's Cancer Prevention Efforts
University of Virginia Health System
More than 30 Southwest Virginia residents on the University of Virginia Cancer Center Without Walls Community Advisory Board have set four regional priorities for cancer prevention and early detection. Their areas of focus are helping residents quit tobacco use, screenings for lung and colorectal cancer, along with efforts to prevent human papillomavirus (HPV), which causes several cancers.
Yale Cancer Center Study Shows Regional Variation in Genomic Testing for Men with Prostate Cancer
Yale Cancer Center
In a new study by Yale Cancer Center, researchers found substantial regional variation in use of genomic testing for prostate cancer, raising questions about access and other factors that might promote rapid adoption of new cancer technologies.
A real life "Superman" celebrates 5 years of survival from one of the deadliest cancers
University Hospitals Cleveland Medical Center
Story of a man who celebrated his five-year survival with GBM. He received 5-ALA prior to surgery, which helps the surgeon see more of the tumor for removal, and he was in a Phase 1 clinical trial.
Stephen Baylin Named Fellow Of The American Association For The Advancement Of Science
Johns Hopkins Medicine
Stephen Baylin, M.D., the Virginia and D.K. Ludwig Professor for Cancer Research, professor of oncology and medicine, and co-director of the Cancer Genetics and Epigenetics Program at the Johns Hopkins Kimmel Cancer Center, has been elected by his peers as a fellow of the American Association for the Advancement of Science (AAAS), an international nonprofit organization dedicated to advancing science, engineering and innovation. Baylin was among 489 AAAS members and four from Johns Hopkins who were selected for their scientifically or socially distinguished efforts to advance science or its applications, according to the organization.
Exploring the Role of Tumor Suppressor Enhancers in the Development of T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer Institute of New Jersey
Researchers from Rutgers Cancer Institute of New Jersey identified a novel enhancer that interacts with a tumor suppressor gene and explored its involvement in normal T-cell development as well as in T-cell acute lymphoblastic leukemia (T-ALL).
CU Cancer Center Leukemia Researcher Receives NCI Outstanding Investigator Award
University of Colorado Cancer Center
Craig Jordan, PhD, has spent more than 20 years developing better treatments for acute myeloid leukemia (AML), a rapidly progressing cancer of the blood and bone marrow that can spread to other parts of the body, including the lymph nodes, liver, spleen and central nervous system.
From the Bench: Taking Steps toward New Lung Cancer Therapies
Rutgers Cancer Institute of New Jersey
As the state's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey, together with RWJBarnabas Health, has the tools and experts to provide exceptional care and conduct cutting-edge research to advance our understanding of lung cancer and pave the way for new therapies. Rutgers Cancer Institute expert shares more on the latest research in lung cancer.
Researchers discover men fighting both cancer and COVID-19 at higher risk than women
University of Kansas Cancer Center
Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.
New targeted therapy blocks metabolism in brain cancer cells with genetic vulnerability
University of Texas M. D. Anderson Cancer Center
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects. Preclinical studies found the small-molecule enolase inhibitor to be effective in killing brain cancer cells that were missing ENO1, one of two genes encoding the enolase enzyme.
Medicaid expansion may result in earlier diagnosis and improved access to treatment of colon cancer
American College of Surgeons (ACS)
The Affordable Care Act's Medicaid expansion for low-income people appears to lead to earlier diagnosis of colon cancer, enhanced access to care, and improved surgical care for patients with this common cancer.
Researchers join $10 million project to understand sex differences in brain cancer outcomes
Penn State College of Medicine
Researchers from Penn State College of Medicine are participating in a $10 million project to better understand why males and females have different survival rates with a common and deadly type of brain cancer.
Alex Trebek's Death Raising Awareness and Questions About Pancreatic Cancer
University of Colorado Cancer Center
Longtime "Jeopardy!" host Alex Trebek announced it to the world on March 6, 2019: Like 50,000 other Americans each year, he had been diagnosed with stage 4 pancreatic cancer.
Roswell Park Reports Positive Outcomes from New Combination Treatment for Ovarian Cancer
Roswell Park Comprehensive Cancer Center
A team from Roswell Park Comprehensive Cancer Center has detailed striking findings on the effectiveness of a previously untried combination of old and new drugs as treatment for recurrent ovarian cancer.
Henry Ford Health System is the First in Michigan to offer da Vinci Single Port Robotic Surgery System
Henry Ford Health System
Henry Ford Health System is the first in Michigan to offer the da Vinci SP(r) robotic surgery system, which requires only a single small incision for its surgical instruments and allows for greater control and access in narrow surgical spaces.
Scientists Discover Roles for a Cellular Motor in Cancer
Huntsman Cancer Institute at the University of Utah
Utah scientists have discovered new functions of a key cellular machine that regulates gene packaging and is mutated in 20% of human cancers. The study was published in print today in the journal Molecular Cell.
Medical Oncologist Dr. Shilpi Gupta Joins Atlantic Health System Cancer Care's Comprehensive Breast Health Program
Atlantic Health System
Atlantic Health System Cancer Care today announced that fellowship-trained medical oncologist, Shilpi Gupta, MD, has joined Morristown Medical Center's comprehensive breast health program where her focus is breast oncology and research. Dr. Gupta is on staff at Atlantic Hematology Oncology at the hospital's Carol G. Simon Cancer Center.
Facing New Challenges: Caregiving, Cancer, and COVID
Rutgers Cancer Institute of New Jersey
November is National Family Caregivers month, a time to recognize those who play an important role in helping a loved one through their cancer journey. Due to the COVID-19 pandemic, caregivers for cancer patients might feel that this role has become more difficult. Experts from Rutgers Cancer Institute share some insight.
Sara Federico, M.D., receives NCI award for her leadership in developing clinical trials for pediatric cancer
St. Jude Children's Research Hospital
Sara Federico, MD, received the NCI award for substantial impact in the field of childhood solid tumors through the development and conduct of clinical trials
Are E-cigarettes Safer Than Cigarettes? Study Sheds Light on the Issue
University of Kansas Cancer Center
Scientists and medical professionals have long debated whether pod e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.
What Drives Painful Bone Metastasis in Prostate Cancer, and Can it Be Prevented?
Roswell Park Comprehensive Cancer Center
While prostate cancer originates within the prostate, metastasis, or the spread of a tumor from the site of origin to other organs, remains a leading cause of death among people with the disease. Prostate tumors can metastasize to a number of different organs, including the liver, lymph nodes and bone.
Researchers Find County Differences in Liver Mortality in the U.S.
University of Miami Health System, Miller School of Medicine
University of Miami Miller School of Medicine and Emory researchers found significant differences in death rates even within the same state, according to a recently published study in Gastroenterology.
Cancer Survivor Dedicates Short Film to SHRO Founder
Sbarro Health Research Organization (SHRO)
Written while the filmmaker was undergoing chemotherapy in 2018, Randa Ghattas' short film, "Hug Me Dad," is dedicated in part to Giordano, who advised her on the course of her treatment.
Advances in Pancreatic Cancer Research and Treatment
Rutgers Cancer Institute of New Jersey
Pancreatic cancer is difficult to detect and treat, so researchers are continually advancing working on understanding of the disease through research. Rutgers Cancer Institute of New Jersey expert shares an overview of research and treatment advances for pancreatic cancer.
Pancreatic Cancer 101: Understanding the Basics
Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey expert addresses what you should know about pancreatic cancer including risks, symptoms and treatment.
Certain CBD oils no better than pure CBD at inhibiting certain cancer cell lines
Penn State College of Medicine
Cannabidiol (CBD) oils are equally or less effective at inhibiting the growth of certain cancer cells compared to pure CBD, according to Penn State College of Medicine researchers.
NYU Langone Health Expands Comprehensive Lung Cancer Care in Brooklyn
NYU Langone Hospital - Brooklyn
NYU Langone Health's Perlmutter Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, in partnership with NYU Langone Hospital-Brooklyn is growing its state-of-the-art lung cancer care in New York City's largest borough with a new expansion of treatment and screening services.
Sylvester Comprehensive Cancer Center Researchers Report Positive Results for New Treatment Strategy for Localized Prostate Cancer
University of Miami Health System, Miller School of Medicine
A Sylvester Comprehensive Cancer Center research team has found that focal high intensity focused ultrasound (HIFU) is an effective strategy for treating localized prostate cancer while minimizing side effects.
Dana-Farber Cancer Institute and Quest Diagnostics collaborate to identify the prevalence of COVID-19 in individuals with precursor to multiple myeloma
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute, one of the world's leading centers of cancer research and treatment, and Quest Diagnostics, (NYSE: DGX), the world's leading provider of diagnostic information services, announced the start of a new research study that provides free COVID-19 antibody testing to individuals who are at high risk of developing multiple myeloma.
Hackensack University Medical Center Holds AirMed Helicopter Fly-In for South Toms River Girl, 4, Who is Fighting Cancer
Hackensack Meridian Health
Hackensack Meridian Hackensack University Medical Center's Air Med helicopter participated in a fly-in event for Sophia Colavito, 4, of South Toms River, New Jersey.
Albert Einstein College of Medicine Researchers Receive $5 Million NIH Grant to Study HIV and HPV Cancers in Africa
Albert Einstein College of Medicine
A team of scientists from Albert Einstein College of Medicine has received a five-year, $4.9 million grant from the National Institutes of Health (NIH) to establish a research center to investigate HIV- and human papillomavirus (HPV)-related cancers in Africa.
Smilow Cancer Hospital Receives CT Lions Eye Research Foundation Grant to Study Eye Cancer
Yale Cancer Center
The Connecticut Lions Eye Research Foundation has awarded a grant to Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center.
Breaking It Down: How Cells Degrade Unwanted MicroRNAs
UT Southwestern Medical Center
DALLAS - Nov. 12, 2020 - UT Southwestern researchers have discovered a mechanism that cells use to degrade microRNAs (miRNAs), genetic molecules that regulate the amounts of proteins in cells.
Personalized drug screens could guide treatment for children with brain cancer
Sanford Burnham Prebys Medical Discovery Institute
Scientists at Sanford Burnham Prebys Medical Discovery Institute, University of California San Diego School of Medicine and Hopp Children's Cancer Center Heidelberg (KiTZ) have demonstrated that personalized drug screens can be used to identify new therapeutic candidates for medulloblastoma. The approach measures the effectiveness of therapeutics using tumor cells obtained from a biopsy and can be performed in a few days--making it one of the quickest sources of information used in clinical decision-making.
Increase in Early-Stage Cancer Diagnoses Tied to ACA's Medicaid Expansion, Pitt Study Finds
Health Sciences at the University of Pittsburgh
The study showed that health insurance expansions increased early-stage cancer diagnoses, while rates of late-stage cancer decreased.
Is proton therapy the silver bullet for children with brain cancer?
University of South Australia
How safe is proton therapy for children with brain cancer compared to the conventional x-ray radiation delivered post-surgery?
New Research in JNCCN Evaluates Cost-Effectiveness of Olaparib, a PARP Inhibitor, for Metastatic Pancreatic Cancer
National Comprehensive Cancer Network(r) (NCCN(r))
New research in the November 2020 issue of JNCCN identifies metastatic pancreatic cancer patient subgroups with the highest relative cost-effectiveness from maintenance olaparib, a PARP inhibitor.
Cancer Research Institute CEO and Director of Scientific Affairs Dr. Jill O'Donnell-Tormey Receives Inaugural Tara Withington Public Service Award from the Society for Immunotherapy of Cancer
Cancer Research Institute
Award honors individuals and organizations that foster and enhance the field of cancer immunotherapy through increasing public understanding, awareness, research efforts, and/or funding
Combination Drug Strategies Gain Ground in Global Immuno-Oncology Pipeline of PD-1 and PD-L1 Clinical Trials, New Report from Cancer Research Institute Reveals
Cancer Research Institute
Analysis update by the nonprofit Cancer Research Institute reveals dramatic growth in PD-1/PD-L1 monoclonal antibody combination cancer treatment strategies in global clinical trial pipeline
'Pinprick' biomarker blood test offers diagnostic potential in HPV-related cancers Study shows rising antibody levels predict the course of cancer
Abviris
A potential breakthrough in the early detection of the neck, head and anal cancers linked to human papilloma viruses (HPV) has emerged. It is based on a highly specific diagnostic test that appears to indicate cancer, and predict its course, from just a pinprick of blood.
Ovarian Cancer Screening Study Focuses on Early Detection in Women at Low Risk
Atlantic Health System
Atlantic Health System is enrolling women in a landmark study that uses a simple blood test for the CA-125 protein to screen women who are at low risk for ovarian cancer. The purpose of the clinical trial is to help determine whether this test can catch ovarian cancer early in women who would not normally be screened for it. Atlantic Health System hospitals are the only centers in the New York metro region to participate in the study, and have the third highest enrollment numbers in the nation.
Take Part in the 2020 Great American Smokeout
Rutgers Cancer Institute of New Jersey
November 19, 2020 marks the Great American Smokeout, an annual intervention hosted by the American Cancer Society as a call to action to take the first step towards better health through the elimination of tobacco products. Rutgers experts share more on why and how to get started.
Learning more about Pancreatic Cancer
Rutgers Cancer Institute of New Jersey
With the recent passing of Jeopardy host Alex Trebek, Rutgers Cancer Institute of New Jersey expert explains pancreatic cancer and the progress being made with this disease through research and clinical trials.
Rutgers Cancer Institute of New Jersey Experts Address Prostate Cancer in Wake of Recent Announcement from Television Personality Al Roker
Rutgers Cancer Institute of New Jersey
A Better Test for the Tumor-Targeting of CAR-T Therapies
Ludwig Cancer Research
Ludwig Cancer Research scientists have developed a method to significantly improve the preclinical evaluation of chimeric antigen-receptor (CAR) T cell therapies, in which the immune system's T cells are extracted from a patient, engineered to target a specific tumor-associated molecule and then grown and reinfused for cancer treatment.
Rutgers Awarded $1.5 Million FEMA Grant to Support Volunteer Firefighter Cancer Research and Prevention
Rutgers School of Public Health
The Rutgers School of Public Health received a $1.5 Million Federal Emergency Management Agency grant to support volunteer firefighter cancer research.
Large-scale cancer proteomics study profiles protein changes in response to drug treatments
University of Texas M. D. Anderson Cancer Center
Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of Texas MD Anderson Cancer Center have generated a valuable resource to aid in predicting drug sensitivity, to understand therapeutic resistance mechanisms and to identify optimal combination treatment strategies.
Studies Show Subcutaneous Methylnaltrexone Provides Safe, Effective, and Rapid Relief of Opioid-Induced Constipation in Patients with Cancer
American Society of Regional Anesthesia and Pain Medicine (ASRA)
In a study of cancer patients treated with methylnaltrexone, about 50%-70% experienced relief from opioid-induced constipation within 4 hours without the use of additional treatments, compared with 15% of placebo-treated patients. In addition, more patients treated with methylnaltrexone maintained a response at 24 hours after dosing compared with patients treated with placebo.
Researchers Uncover New Mechanism of Immune-Cell Activation
Yale Cancer Center
In a new study by Yale Cancer Center, scientists have identified the short endosomal protein interferon-inducible transmembrane protein 3 or IFITM3 as a central amplifier to supercharge activation of immune cells.
Cancer treatment could be replicated for COVID-19
University of South Australia
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists.
Immunotherapy Side Effect Could Be A Positive Sign For Kidney Cancer Patients
UT Southwestern Medical Center
DALLAS - Nov. 2, 2020 - An autoimmune side effect of immune checkpoint inhibitor (ICI) drugs could signal improved control of kidney cancer, according to a new study by researchers in UT Southwestern's Kidney Cancer Program (KCP).
Age Is A Primary Determinant Of Melanoma Treatment Resistance, Two Studies Find
Johns Hopkins Medicine
Age may cause identical cancer cells with the same mutations to behave differently. In animal and laboratory models of melanoma cells, age was a primary factor in treatment response.
Exploring Autophagy as a Therapeutic Strategy against Frequent Mutations in Non-Small Cell Lung Cancer
Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey expert investigates the role of a cellular survival mechanism known as autophagy in the formation of tumors driven by mutations in tumor suppressors known as LKB1 and oncogene KRAS.
Roswell Park Sees Suggestion of Benefit in First Clinical Trial to Combine Beta-Blocker and Checkpoint Inhibitor
Roswell Park Comprehensive Cancer Center
The same biochemical triggers that spur a "fight or flight" response when we encounter threats may help tumor cells to thrive. A team of researchers from Roswell Park Comprehensive Cancer Center is looking at ways to disrupt that dynamic so that cancer treatments can be more effective. Their latest work, published today in Clinical Cancer Research, a journal of the American Association for Cancer Research, suggests that a drug widely prescribed to control blood pressure may improve patients' response to cancer immunotherapy.
ORNL researcher studies individualized isotopes' impact by targeting cancer
Oak Ridge National Laboratory
A radioisotope researcher in the Radioisotope Science and Technology Division at the Department of Energy's Oak Ridge National Laboratory, Davern is focusing on ways to use nanoparticles -- particles 100 nanometers or smaller that can have special properties -- to contain those radioisotopes and deliver them directly to cancer cells, where they can decay into different isotopes that irradiate those cells.
Mass Eye and Ear Capital Campaign Concludes with $252 Million Raised to Advance Research and Patient Care
Massachusetts Eye and Ear
Mass Eye and Ear is proud to announce the successful conclusion of its historic campaign, "Bold Science. Life-Changing Cures." which raised $252M from philanthropy to advance research to treat and cure diseases of vision, hearing, and the head and neck. The campaign was led by co-chair Wyc Grousbeck, Boston Celtics CEO and Lead Owner and former Chairman of Mass Eye and Ear.
Accelerating Access to Breakthrough Cancer Therapies Leads Morristown Medical Center to Expand Infusion Center
Atlantic Health System
Atlantic Health System has announced the opening of Morristown Medical Center's new state-of-the-art, patient-centered Infusion Center located in the Carol G. Simon Cancer Center. The first of three phases of expansion of New Jersey's pre-eminent cancer center, the new unit was funded in large part by donations made by community members in support of the Foundation for Morristown Medical Center's Growing Forward Campaign.
Cancer-Fighting Gene Restrains 'Jumping Genes'
UT Southwestern Medical Center
DALLAS - Oct. 29, 2020 - About half of all tumors have mutations of the gene p53, normally responsible for warding off cancer. Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, or "jumping genes," from hopping around the human genome. In cells with missing or mutated p53, the team found, retrotransposons move and multiply more than usual. The finding could lead to new ways of detecting or treating cancers with p53 mutations.
First Came Breast Cancer, Then COVID-19
Cedars-Sinai
Natalie Coehlo wasn't concerned at first about the sudden rash on her left breast last December. Six months later, though, when the rash had morphed into sores, she visited her primary care physician in Tulare, California.
Rutgers Cancer Institute of New Jersey Expert Addresses Revised Age Recommendation for Colorectal Cancer Screening
Rutgers Cancer Institute of New Jersey
Cancer's Dangerous Renovations to Our Chromosomes Revealed
University of Virginia Health System
Cancer remodels the architecture of our chromosomes so the disease can take hold and spread, new research reveals.
Dermatologist Saves South Florida Man's Life with Early Diagnosis of Lung Cancer
American Academy of Dermatology
The American Academy of Dermatology named board-certified dermatologist Brittany Smirnov, DO, FAAD, a Patient Care Hero for her role in diagnosing and treating a patient with stage IV metastatic lung cancer.
New Roswell Park Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells
Roswell Park Comprehensive Cancer Center
Research led by a team from Roswell Park Comprehensive Cancer Center details a promising new strategy for overcoming resistance to immunotherapy by zeroing in on dendritic cells and enhancing their function as "accessory cells" supporting other immune cells.
Cancer Treatment Without Side Effects?
University of California, Irvine
Irvine, Calif., Oct. 27, 2020 - Treating cancer without debilitating side effects has long been the holy grail of oncologists, and researchers at the University of California, Irvine and Switzerland's Lausanne University Hospital may have found it. Charles Limoli, professor of radiation oncology at UCI, and Marie-Catherine Vozenin, associate professor of radiation oncology at the Swiss facility, used an ultra-high dose rate of radiation therapy to eliminate brain tumors in mice, bypassing key side effects usually caused by cranial irradiation.
Cancer cells mediate immune suppression in the brain
University of Notre Dame
Notre Dame researchers showed that one type of cell important for immunity, called a myeloid cell, can suppress the immune response -- which has the effect of allowing breast cancer cells to metastasize to the brain to form secondary tumor cells there.
NCCN Announces Beth Gaffney, MBA, as New Vice President of U.S. and Global Business Development
National Comprehensive Cancer Network(r) (NCCN(r))
The National Comprehensive Cancer Network(r) (NCCN(r)) today announced the addition of Beth Gaffney, MBA, as the new Vice President of U.S. and Global Business Development, overseeing licensing and other collaborations.
Activating "Inflammasome" May Improve Cancer's Response To Immunotherapy And Parp Inhibitors
Johns Hopkins Medicine
The inflammasome--a protein signaling network that is activated to rid the body of virus or bacteria-infected cells--may play an important role in triggering an immune response to cancer and causing an existing class of drugs to work better against cancers.
Breast cancer screening by age 40 or younger for Black women advise Beaumont researchers
Beaumont Health
The physicians focused on how Black women dealt with getting screened and unique issues relevant to them. They revealed their findings recently in the Journal of Breast Imaging in "Breast Cancer Screening Recommendations: African American Women Are at a Disadvantage."
New Map of the Immune Landscape in Pancreatic Cancer Could Guide Future Personalized Immunotherapy Treatments
Michigan Medicine - University of Michigan
A new analysis highlights the diversity of immune response in pancreatic cancer, and points toward the need for treatments tailored to individual patients.
Some rectal cancer patients can safely avoid an aggressive operation
American College of Surgeons (ACS)
A nonsurgical treatment option for rectal cancer that preserves quality of life is safe for carefully selected patients, according to a new study comparing it with the standard operation. The study results appear online as an "article in press" on the Journal of the American College of Surgeons website in advance of print publication and were presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
American College of Gastroenterology Announces Winners of Sixth Annual SCOPYs: Service Award for Colorectal Cancer Outreach, Prevention, and Year-Round Excellence
American College of Gastroenterology (ACG)
The American College of Gastroenterology (ACG) announces the winners of the 2020 SCOPY Awards (Service Award for Colorectal Cancer Outreach, Prevention, and Year-Round Excellence) to recognize the achievements of ACG members in their community engagement, education and awareness efforts for colorectal cancer prevention.
New Clinical Advances in Gastroenterology Presented at the American College of Gastroenterology's 85th Annual Scientific Meeting
American College of Gastroenterology (ACG)
More than 7,000 gastroenterologists and other health care professionals so far will convene virtually for the premier clinical gastroenterology event--the American College of Gastroenterology's 85th Annual Scientific Meeting and Postgraduate Course (Virtual ACG 2020)--to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases, and clinical practice management.
Targeted inhibitor of mutated KRAS gene shows promise in early trial for lung, bowel, and other solid tumors
Dana-Farber Cancer Institute
A novel agent that targets a mutated form of the KRAS gene - the most commonly altered oncogene in human cancers and one long considered "undruggable" - shrank tumors in most patients in a clinical trial with manageable side effects, researchers reported today at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Therapeutic, which is taking place online.
Studying Patterns of Relapse in Pediatric Hodgkin Lymphoma using a Response-Based Therapy Approach
Rutgers Cancer Institute of New Jersey
Recent research from Rutgers Cancer Institute of New Jersey expert as part of a phase 3 study from the Children's Oncology Group explores response-based consolidation with modern radiation therapy as safe and effective standard of care for pediatric Hodgkin lymphoma patients. This work is being presented at the Annual Meeting of the American Society for Radiation Oncology (ASTRO) this week.
How a Twitter hashtag provides insights for doctors and support for people with breast cancer
University of California, Los Angeles (UCLA), Health Sciences
A UCLA-led review of nine years of social media posts with the hashtag #BCSM suggests that Twitter can be a useful resource not only for patients, but also for physicians and researchers.
DrugCell: New Experimental AI Platform Matches Tumor to Best Drug Combo
University of California San Diego Health
UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer.
Toward a New Staging System for Prostate Cancer, and Why it Matters
Michigan Medicine - University of Michigan
The development and validation of a staging system for non-metastatic prostate cancer could help doctors and patients assess treatment options, as well as improve clinical trials.
New experimental blood test determines which pancreatic cancers will respond to treatment
Van Andel Institute
GRAND RAPIDS, Mich. (Oct. 22, 2020) -- Scientists have developed a simple, experimental blood test that distinguishes pancreatic cancers that respond to treatment from those that do not. This critical distinction could one day guide therapeutic decisions and spare patients with resistant cancers from undergoing unnecessary treatments with challenging side effects.
Rogel team receives $11.2M to leverage the microbiome against GVHD
Michigan Medicine - University of Michigan
A team of researchers from the Rogel Cancer Center received an $11.2 million grant from the National Heart, Lung and Blood Institute to study how to use the microbiome to limit complications of stem cell transplants for blood cancers and other diseases.
Dr. Michaela Dinan Named Co-Leader of the Cancer Prevention and Control Research Program at Yale Cancer Center
Yale Cancer Center
Michaela A. Dinan, PhD, has been appointed Co-Leader of the Cancer Prevention and Control Research Program at Yale Cancer Center.
Genome archeologists discover a path to activate the immune response against cancer
University Health Network (UHN)
Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.
Tumor DNA in Spinal Fluid Could Help Doctors Better Monitor Childhood Brain Cancer
Michigan Medicine - University of Michigan
Researchers have demonstrated that a new liquid biopsy approach overcomes traditional barriers to quickly and efficiently diagnose and monitor high-grade pediatric gliomas.
Study reports chemical mechanism that boosts enzyme observed in cancer
Indiana University
A study led by researchers at IUPUI and Indiana University Bloomington is the first to describe a biochemical mechanism that influences activity in a protein linked to cancer, aging, inflammatory responses and addiction-related behaviors.
Jeff Bridges Has Lymphoma--Here's What to Know About This Form of Cancer, and What His Treatment Might Involve
Hackensack Meridian Health
Rutgers Cancer Institute of New Jersey Expert Addresses Lymphoma in Wake of Recent Announcement from Actor Jeff Bridges
Rutgers Cancer Institute of New Jersey
New approach to fighting cancer could reduce costs and side effects
University of South Australia
CAR-T biotherapeutics company Carina Biotech and researchers at the University of South Australia have developed a novel approach based on microfluidic technology to "purify" the immune cells of patients in the fight against cancer.
Focus Fund and MD Anderson launch investment fund to support promising investigational cancer therapies in early-stage clinical trials
University of Texas M. D. Anderson Cancer Center
The Focus Fund GP, LLC, in partnership with The University of Texas MD Anderson Cancer Center, has launched Cancer Focus Fund, LP, an oncology-focused investment fund designed to support the advancement of compelling investigational cancer therapies from late preclinical development through Phase I and Phase Ib/II clinical trials.
Cancer Metabolism Researcher Ralph Deberardinis Elected to The National Academy of Medicine
UT Southwestern Medical Center
DALLAS - Oct. 19, 2020 - Ralph DeBerardinis, M.D., Ph.D., a professor at the Children's Medical Center Research Institute at UT Southwestern (CRI), has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.
UCLA physician-scientist elected to National Academy of Medicine
University of California, Los Angeles (UCLA), Health Sciences
Dr. Antoni Ribas, a world-renowned physician-scientist and professor of medicine at the David Geffen School of Medicine at UCLA, has been named to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.
Highlighting the Unique Role of the Oncology Pharmacist and Pharmacy Technician
Rutgers Cancer Institute of New Jersey
With specialized knowledge about medications and how they work to fight cancer, oncology pharmacists and pharmacy technicians play a vital role in patient care and research.
Huntsman Cancer Institute Leadership Announcement: Cairns Named Chief Academic Officer, Welm Named Senior Director of Basic Science
Huntsman Cancer Institute at the University of Utah
Today, Huntsman Cancer Institute (HCI) at the University of Utah (U of U) announced new leadership appointments for two long-standing cancer center members.